更新时间: 2025/01/10 43.7599.75155.75211.75264.00过去12个月未来12个月最高220.00平均178.70最低160.00现价135.91 经营数据 业务营收 338.80亿 254.10亿 169.40亿 84.70亿 0 2024/Q3 2024/Q4 2025/Q1 2025/Q2 2025/Q3 数据中心 游戏业务 专业可视化
更新时间: 2025/01/17 45.67100.67155.67210.67264.00过去12个月未来12个月最高220.00平均177.42最低135.00现价137.71 经营数据 业务营收 338.80亿 254.10亿 169.40亿 84.70亿 0 2024/Q3 2024/Q4 2025/Q1 2025/Q2 2025/Q3 数据中心 游戏业务 专业可视化
NVDA Stock 12 Month Forecast All Analysts Top Analysts Average Price Target $177.08 ▲(26.78% Upside) Past 12 Months12 Month ForecastMar2024Dec2024 High $220.00 Average $177.08 Low $135.00 Detailed Analyst Forecast > Technical Analysis 1 Day 3 Days 1 Week 1 Month Overall Consensu...
NVDA Stock 12 Month Forecast Average Price Target $176.86 ▲(20.13% Upside) Based on 39 Wall Street analysts offering 12 month price targets for Nvidia in the last 3 months. The average price target is $176.86 with a high forecast of $220.00 and a low forecast of $135.00. The average ...
3D Systems Plunges 20% in a Month: Buy, Sell or Hold the Stock? Dec. 9, 2024 at 11:48 a.m. ET on Zacks.com AMD Shares Dips 4% as BofA Cuts Price Target, Citing PC Market Headwinds Dec. 9, 2024 at 11:22 a.m. ET on GuruFocus.com Chinese Antitrust Investigation Into ...
2025-01-07 137.321 132.516 142.224 NVDA Target Price NVDA price target in 14 days: 147.043 USD* upside and 132.516 USD* downside. (Highest and lowest possible predicted price in a 14 day period) Detailed Trend Components of the NVIDIA Corporation Stock Price Forecast & Prognosis Walletinvestor....
Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.
高盛建议投资者在2025年持有人工智能龙头股和周期性股,并将以下股票列为“买入”评级:英伟达(NVDA.US)、博通(AVGO.US)、泛林集团(LRCX.US)、美光科技(MU.US)、泰瑞达(TER.US)、英特格(ENTG.US)和恩智浦。 在软件领域,公司管理层表示市场环境稳定,这与高盛2025年软件展望报告一致。该报告显示,在经历了多年的...
智通财经APP获悉,浙商证券发布研报称,英伟达(NVDA.US)或将于2025年3月的GTC大会揭露GB300产品线,Semianalysis预计GB300将在GB200推出的6个月后面世。GB200于24Q4少量发货,25Q1逐季放量,预计GB300的芯片出货时间在25年年中,芯片版本更新迭代的速度加快。同时,GB300或将成为Blackwell系列的主力产品。
TSLA's current last sale is 163.26% of the target price of $278.Silexion Therapeutics Corp (SLXN) is +0.25 at $2.39, with 4,235,383 shares traded. As reported by Zacks, the current mean recommendation for SLXN is in the "strong buy range".SoundHound AI, Inc. ...